Moderna
MRNA
#1404
Rank
โ‚ฌ13.62 B
Marketcap
34,86ย โ‚ฌ
Share price
2.47%
Change (1 day)
1.80%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Market capitalization of Moderna (MRNA)

Market cap: โ‚ฌ13.62 Billion

As of January 2026 Moderna has a market cap of โ‚ฌ13.62 Billion. This makes Moderna the world's 1404th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Moderna from 2018 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚ฌ13.62 B31.25%
2025โ‚ฌ10.37 B-30.07%
2024โ‚ฌ14.84 B-56.74%
2023โ‚ฌ34.30 B-46.68%
2022โ‚ฌ64.33 B-29.25%
2021โ‚ฌ90.92 B170.54%
2020โ‚ฌ33.60 B471.97%
2019โ‚ฌ5.87 B33.89%
2018โ‚ฌ4.38 B

End of Day market cap according to different sources

On Jan 13th, 2026 the market cap of Moderna was reported to be:

โ‚ฌ13.28 Billion
by Nasdaq info icon info icon
โ‚ฌ13.29 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Regulus Therapeutics
RGLS
โ‚ฌ0.48 B-96.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ238.18 B 1,648.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
โ‚ฌ0.71 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚ฌ41.63 B 205.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ240.90 B 1,668.74%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Arrowhead Pharmaceuticals
ARWR
โ‚ฌ7.89 B-42.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚ฌ452.30 B 3,220.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
โ‚ฌ2.55 B-81.22%๐Ÿ‡บ๐Ÿ‡ธ USA